Oppenheimer Lowers PT on Genpact to $19

Oppenheimer is out with its report today on Genpact G, lowering its PT to $19 from $20. In its report, Oppenheimer writes, "We are slightly revising our estimates and price target for Genpact. Our FY11 estimates are now 1.573B/$0.86 from $1.574B/$0.88. For FY12 our estimates are lowered to $1.864B/$1.00 from prior $1.887B/$1.04. We are subsequently lowering our price target for Genpact from prior $20 to $19 to reflect lower estimates." Oppenheimer maintains Outpeform on G. At the time of posting, shares of G were trading at $16.13, up 1.57% from Friday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsData Processing & Outsourced ServicesInformation TechnologyOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!